Emerald Mutual Fund Advisers Trust Sells 379,293 Shares of Rxo Inc $RXO

Emerald Mutual Fund Advisers Trust decreased its stake in Rxo Inc (NYSE:RXO) by 88.8% during the 3rd quarter, HoldingsChannel reports. The fund owned 47,836 shares of the company’s stock after selling 379,293 shares during the period. Emerald Mutual Fund Advisers Trust’s holdings in RXO were worth $736,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Yousif Capital Management LLC boosted its holdings in RXO by 1.2% in the 2nd quarter. Yousif Capital Management LLC now owns 53,228 shares of the company’s stock valued at $837,000 after purchasing an additional 631 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH raised its position in shares of RXO by 6.1% during the third quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,453 shares of the company’s stock valued at $176,000 after buying an additional 654 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of RXO by 3.3% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 20,428 shares of the company’s stock valued at $345,000 after buying an additional 661 shares during the period. New York State Teachers Retirement System grew its position in RXO by 0.6% during the third quarter. New York State Teachers Retirement System now owns 116,604 shares of the company’s stock worth $1,793,000 after buying an additional 700 shares in the last quarter. Finally, Maryland State Retirement & Pension System grew its position in RXO by 1.8% during the second quarter. Maryland State Retirement & Pension System now owns 41,910 shares of the company’s stock worth $659,000 after buying an additional 751 shares in the last quarter. 92.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on RXO. Stifel Nicolaus raised their price objective on RXO from $15.00 to $16.00 and gave the stock a “hold” rating in a research report on Tuesday, December 16th. TD Cowen restated a “hold” rating on shares of RXO in a research note on Friday, January 9th. The Goldman Sachs Group decreased their price target on shares of RXO from $17.00 to $15.00 and set a “neutral” rating on the stock in a research note on Thursday, October 9th. Wolfe Research raised shares of RXO from an “underperform” rating to a “peer perform” rating in a report on Friday, November 14th. Finally, UBS Group dropped their price objective on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Four equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.14.

Insider Buying and Selling

In other news, Director Thomas A. Szlosek acquired 20,308 shares of the firm’s stock in a transaction on Friday, November 7th. The shares were purchased at an average cost of $12.37 per share, with a total value of $251,209.96. Following the completion of the purchase, the director owned 36,508 shares of the company’s stock, valued at $451,603.96. This represents a 125.36% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Andrew M. Wilkerson acquired 7,775 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were purchased at an average cost of $12.88 per share, with a total value of $100,142.00. Following the acquisition, the chief executive officer owned 7,775 shares of the company’s stock, valued at approximately $100,142. This represents a ? increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 40,250 shares of company stock worth $488,875 in the last quarter. 2.80% of the stock is owned by corporate insiders.

RXO Price Performance

Shares of RXO stock opened at $15.55 on Friday. The stock’s fifty day simple moving average is $13.68 and its 200 day simple moving average is $15.27. Rxo Inc has a one year low of $10.43 and a one year high of $26.92. The firm has a market cap of $2.55 billion, a price-to-earnings ratio of -36.15, a P/E/G ratio of 7.73 and a beta of 1.74. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.32 and a quick ratio of 1.32.

RXO (NYSE:RXO) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). RXO had a negative net margin of 1.25% and a positive return on equity of 0.88%. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the previous year, the business posted $0.05 earnings per share. The firm’s revenue was up 34.6% compared to the same quarter last year. On average, analysts expect that Rxo Inc will post 0.31 earnings per share for the current fiscal year.

RXO Company Profile

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.